148 related articles for article (PubMed ID: 9700007)
1. Ocular findings in familial adenomatous polyposis.
Gelisken O; Yücel A; Güler K; Zorluoglu A
Int Ophthalmol; 1997-1998; 21(4):205-8. PubMed ID: 9700007
[TBL] [Abstract][Full Text] [Related]
2. Retinal pigment epithelium lesions as a biomarker of disease in patients with familial adenomatous polyposis. A follow-up report.
Romania A; Zakov ZN; Church JM; Jagelman DG
Ophthalmology; 1992 Jun; 99(6):911-3. PubMed ID: 1321393
[TBL] [Abstract][Full Text] [Related]
3. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP).
Rossato M; Rigotti M; Grazia M; Turco AE; Bonomi L
Acta Ophthalmol Scand; 1996 Aug; 74(4):338-42. PubMed ID: 8883546
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis.
Ruhswurm I; Zehetmayer M; Dejaco C; Wolf B; Karner-Hanusch J
Am J Ophthalmol; 1998 May; 125(5):680-6. PubMed ID: 9625552
[TBL] [Abstract][Full Text] [Related]
5. Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.
Parisi ML
J Am Optom Assoc; 1995 Feb; 66(2):106-12. PubMed ID: 7714311
[TBL] [Abstract][Full Text] [Related]
6. The importance of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis.
Martow J; Polomeno RC; Lewandowski R; Daly D; Miller S; Jutras L; Koehn D; Der Kaloustian VM
Can J Ophthalmol; 1990 Oct; 25(6):290-2. PubMed ID: 2174290
[TBL] [Abstract][Full Text] [Related]
7. [Retinal changes in patients with familial adenomatous polyposis].
Cymerys E; Pecold K; Paszkowski J; Banasiewicz T; Krokowicz P
Klin Oczna; 2006; 108(1-3):70-2. PubMed ID: 16883945
[TBL] [Abstract][Full Text] [Related]
8. Fundus lesions of adenomatous polyposis.
Tiret A; Parc C
Curr Opin Ophthalmol; 1999 Jun; 10(3):168-72. PubMed ID: 10537774
[TBL] [Abstract][Full Text] [Related]
9. Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.
Nusliha A; Dalpatadu U; Amarasinghe B; Chandrasinghe PC; Deen KI
BMC Res Notes; 2014 Oct; 7():734. PubMed ID: 25326340
[TBL] [Abstract][Full Text] [Related]
10. Fluorescein angiographic features of the congenital hypertrophy of the retinal pigment epithelium in the familial adenomatous polyposis.
Touriño R; Rodríguez-Ares MT; López-Valladares MJ; Gómez-Ulla F; Gómez-Torreiro M; Capeans C
Int Ophthalmol; 2005; 26(1-2):59-65. PubMed ID: 16779566
[TBL] [Abstract][Full Text] [Related]
11. Changes in the retinal pigment epithelium close to retinal vessels in familial adenomatous polyposis.
Schmidt D; Jung CE; Wolff G
Graefes Arch Clin Exp Ophthalmol; 1994 Feb; 232(2):96-102. PubMed ID: 8157181
[TBL] [Abstract][Full Text] [Related]
12. Congenital hypertrophy of the retinal pigment epithelium associated with familial adenomatous polyposis.
Santos A; Morales L; Hernandez-Quintela E; Jiménez-Sierra JM; Villalobos JJ; Panduro A
Retina; 1994; 14(1):6-9. PubMed ID: 8016465
[TBL] [Abstract][Full Text] [Related]
13. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP).
Bertario L; Bandello F; Rossetti C; Sala P; Fortini E; Spinelli P; Gennari L; Pietroiusti M; Presciuttini S
Eur J Cancer Prev; 1993 Jan; 2(1):69-75. PubMed ID: 8381318
[TBL] [Abstract][Full Text] [Related]
14. Congenital hypertrophy of the retinal pigment epithelium and familial adenomatous polyposis.
McKay DL
Aust N Z J Ophthalmol; 1993 Feb; 21(1):3-6. PubMed ID: 8388223
[TBL] [Abstract][Full Text] [Related]
15. [Interest in ophthalmologic examination for familial adenomatous polyposis].
Collignon N; Collignon-Brach J; Galand A
Bull Soc Belge Ophtalmol; 1999; 274():11-6. PubMed ID: 10670158
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography findings of pigmented fundus lesions in familial adenomatous polyposis.
Tzu JH; Cavuoto KM; Villegas VM; Dubovy SR; Capo H
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(1):69-70. PubMed ID: 24266367
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the value of congenital hypertrophy of the retinal pigment epithelium as an ocular marker for familial adenomatous polyposis coli.
Hickey-Dwyer MU; Willoughby CE
Eye (Lond); 1993; 7 ( Pt 4)():562-4. PubMed ID: 8253239
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of fundus examination in familial adenomatous polyposis.
Tiret A; Taiel-Sartral M; Tiret E; Laroche L
Br J Ophthalmol; 1997 Sep; 81(9):755-8. PubMed ID: 9422927
[TBL] [Abstract][Full Text] [Related]
19. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis.
Berk T; Cohen Z; McLeod RS; Parker JA
Dis Colon Rectum; 1988 Apr; 31(4):253-7. PubMed ID: 2896112
[TBL] [Abstract][Full Text] [Related]
20. Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis.
Polkinghorne PJ; Ritchie S; Neale K; Schoeppner G; Thomson JP; Jay BS
Eye (Lond); 1990; 4 ( Pt 1)():216-21. PubMed ID: 2157613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
